HomeNews

News

  • Alzheimer’s effects reversed in Mice with an Asthma drug

    • June 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder appoints new CEO to better prepare for Migraine drug launch

    • June 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Atrophied Brain Lesion Volume could be a new biomarker for Progressive MS, study suggests

    • June 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spiriva Respimat gets UK license for young asthma patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Kalydeco (ivacaftor) Data Demonstrates Early and Long-Term Disease-Modifying Potential of Treating the Underlying Cause of Cystic Fibrosis

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ph 2 data for Ublituximab shows encouraging efficacy results in RMS patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Oxford BioMedica & Axovant Sciences sign a $842.5 Mn deal for Parkinson’s Drug

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ph 3 data for Rimegepant in Acute Migraine to be presented at AHC annual scientific meeting 2018

    • June 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • TENS could be a new treatment for Migraine, finds study

    • June 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • VAYA Pharma Launches Vayarin Plus for ADHD patients

    • June 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more